p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation
Mf. Fu et al., p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation, J BIOL CHEM, 275(27), 2000, pp. 20853-20860
The androgen receptor (AR) is a sequence-specific DNA-binding protein that
plays a key role in prostate cancer cellular proliferation by dihydrotestos
terone and the induction of secondary sexual characteristics. In this study
me demonstrate that the AR can be modified by acetylation in vitro and in
vivo, p300 and p300/cAMP-response element-binding protein acetylated the AR
at a highly conserved lysine-rich motif carboxyl-terminal to the zinc fing
er DNA-binding domain. [C-14]acetate-labeling experiments demonstrated that
AR acetylation by p300 in cultured cells requires the same residues identi
fied in vitro. Point mutation of the AR acetylation site (K632A/K633A) abro
gated dihydrotestosterone-dependent transactivation of the AR in cultured c
ells. Mutation of the p300 CH3 region or the p300/cAMP-response element-bin
ding protein histone acetylase domain reduced ligand-dependent AR function.
The identification of the AR as a direct target of histone acetyltransfera
se co-activators has important implications for targeting inhibitors of AR
function.